Health
CN Bio partners with Imperial College London to uncover therapeutic targets for alcoholic hepatitis – News-Medical.net
CN Bio, a leading cell culture company, that has developed single and multi-organ microphysiological systems to improve the accuracy and efficiency of drug discovery, today announced a collaboration with Imperial College London, a world-class research univer…
CN Bio, a leading cell culture company, that has developed single and multi-organ microphysiological systems (MPS) to improve the accuracy and efficiency of drug discovery, today announced a collaboration with Imperial College London, a world-class research university. The research will harness CN Bio’s Liver-on-Chip technology to advance the understanding of the underlying mechanisms of alcoholic hepatitis and uncover novel targets for drug discovery and development.
Despite being an increasin…
-
Noosa News18 hours agoYoung voices shape Sunshine Coast’s future
-
Business18 hours ago2 Low Cost Active ASX ETFs to consider
-
Noosa News16 hours agoAnother All-Star Cast, Another Tale of Family Chaos: The Trailer for Wes Anderson’s ‘The Phoenician Scheme’ Is Here
-
Business14 hours agoshould I buy hedged or unhedged ASX US-focused ETFs?